TY - JOUR
T1 - L-deprenyl (selegiline) decreases excitatory synaptic transmission in the rat hippocampus via a dopaminergic mechanism
AU - Hsu, Kuei Sen
AU - Huang, Chiung Chun
AU - Su, Mei Tsu
AU - Tsai, Jing Jane
PY - 1996/11
Y1 - 1996/11
N2 - The effect of L-deprenyl (selegiline) on the excitatory synaptic transmission was characterized in the CA1 neurons of rat hippocampal slices by using a intracellular recording technique. Superfusion of L-deprenyl (0.1- 10 μM) reversibly decreased the EPSP, which was evoked by orthodromic stimulation of the Schaffer collateral-commissural afferent pathway in a concentration-dependent manner. The sensitivity of postsynaptic neurons to the glutamate receptor agonists, α-amino-3-hydroxy-5-methylisoxazole-4- propionic acid or N-methyl-D-aspartate, was not affected by L-deprenyl (1 μM) pretreatment. In addition, L-deprenyl (1 αM) clearly increased the magnitude of paired-pulse facilitation regardless of the interstimulus intervals of 20 to 300 msec used. The ability of L-deprenyl to decrease the EPSP amplitude was not observed in the dopamine-depleted rats. Pargyline and 4-phenylpyridine, the monoamine oxidase type B inhibitors, mimicked the depressant effect of L-deprenyl on the EPSP. Moreover, the reduction of L- deprenyl (1 μM) on the EPSP amplitude was specifically antagonized by sulpiride (0.01-0.1 μM), a selective dopamine D2 receptor antagonist. However, the dopamine D1 receptor antagonist, SKF-83566 (1-10 μM), did not significantly affect L-deprenyl's action. These results indicate that the monoamine oxidase type B inhibitory ability leading to an increase of the dopaminergic tonus in the hippocampus is involved in the L-deprenyl-induced depression of excitatory synaptic transmission in the CA1 region of the rat hippocampus. Moreover, application of L-deprenyl (1 and 10 μM) also reversibly suppressed the epileptiform activity evoked by picrotoxin.
AB - The effect of L-deprenyl (selegiline) on the excitatory synaptic transmission was characterized in the CA1 neurons of rat hippocampal slices by using a intracellular recording technique. Superfusion of L-deprenyl (0.1- 10 μM) reversibly decreased the EPSP, which was evoked by orthodromic stimulation of the Schaffer collateral-commissural afferent pathway in a concentration-dependent manner. The sensitivity of postsynaptic neurons to the glutamate receptor agonists, α-amino-3-hydroxy-5-methylisoxazole-4- propionic acid or N-methyl-D-aspartate, was not affected by L-deprenyl (1 μM) pretreatment. In addition, L-deprenyl (1 αM) clearly increased the magnitude of paired-pulse facilitation regardless of the interstimulus intervals of 20 to 300 msec used. The ability of L-deprenyl to decrease the EPSP amplitude was not observed in the dopamine-depleted rats. Pargyline and 4-phenylpyridine, the monoamine oxidase type B inhibitors, mimicked the depressant effect of L-deprenyl on the EPSP. Moreover, the reduction of L- deprenyl (1 μM) on the EPSP amplitude was specifically antagonized by sulpiride (0.01-0.1 μM), a selective dopamine D2 receptor antagonist. However, the dopamine D1 receptor antagonist, SKF-83566 (1-10 μM), did not significantly affect L-deprenyl's action. These results indicate that the monoamine oxidase type B inhibitory ability leading to an increase of the dopaminergic tonus in the hippocampus is involved in the L-deprenyl-induced depression of excitatory synaptic transmission in the CA1 region of the rat hippocampus. Moreover, application of L-deprenyl (1 and 10 μM) also reversibly suppressed the epileptiform activity evoked by picrotoxin.
UR - http://www.scopus.com/inward/record.url?scp=0030434805&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030434805&partnerID=8YFLogxK
M3 - Article
C2 - 8930179
AN - SCOPUS:0030434805
SN - 0022-3565
VL - 279
SP - 740
EP - 747
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -